Mackenzie Financial’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $645K | Sell |
138,092
-4,012
| -3% | -$18.7K | ﹤0.01% | 1142 |
|
|
2025
Q1 | $780K | Buy |
142,104
+12,152
| +9% | +$66.7K | ﹤0.01% | 1047 |
|
|
2024
Q4 | $441K | Buy |
129,952
+106,153
| +446% | +$360K | ﹤0.01% | 1228 |
|
|
2024
Q3 | $67.8K | Buy |
+23,799
| New | +$67.8K | ﹤0.01% | 1516 |
|
|
2024
Q2 | – | Sell |
-35,375
| Closed | -$78.2K | – | 1640 |
|
|
2024
Q1 | $78.2K | Buy |
35,375
+9,397
| +36% | +$20.8K | ﹤0.01% | 1446 |
|
|
2023
Q4 | $61K | Hold |
25,978
| – | – | ﹤0.01% | 1434 |
|
|
2023
Q3 | $42.6K | Hold |
25,978
| – | – | ﹤0.01% | 1420 |
|
|
2023
Q2 | $66.2K | Buy |
+25,978
| New | +$66.2K | ﹤0.01% | 1435 |
|